Dachaigh › Leukemia myeloid geur › Washington

Sgrùdaidhean clionaigeach Leukemia myeloid geur ann an Washington

Tha 42 sgrùdaidhean airson Leukemia myeloid geur a’ lorg phàirtichean aig làraichean ann an Washington.

Bailtean ann an Washington

Teacsa sgrùdaidh oifigeil (Beurla)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Fred Hutchinson Cancer Center, Seattle
agus 2 a bharrachd

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564390

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Seattle Children's Hospital, Seattle

A’ fastadhÌre 1

Suas gu aois 21 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07012044

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
agus 19 a bharrachd

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain

Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Fred Hutchinson Cancer Center, Seattle

A’ fastadhÌre 1

Aoisean 12 gu 78 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT03802695

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Swedish Medical Center-First Hill, Seattle

A’ fastadhÌre 2

Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Swedish Cancer Institute, Seattle
Fred Hutchinson Cancer Center, Seattle

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Swedish Medical Center-First Hill, Seattle

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Swedish Medical Center-First Hill, Seattle

A’ fastadhÌre 2

Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Fred Hutchinson Cancer Center, Seattle
agus 2 a bharrachd

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Seattle Children's Hospital, Seattle
Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Mary Bridge Children's Hospital and Health Center, Tacoma
agus 1 a bharrachd

A’ fastadhÌre 3

6 Months – 21 Years · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04293562

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04282187

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04375631

FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07645469

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadh

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07094750

A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell Transplant

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadh

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07616921

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Providence Sacred Heart Medical Center and Children's Hospital, Spokane

A’ fastadhÌre 3

Aoisean 1 gu 25 · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07022678

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

Fred Hutchinson Cancer Center, Seattle

A’ fastadhÌre 1

Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06834282

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Seattle Children's Hospital, Seattle
Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Mary Bridge Children's Hospital and Health Center, Tacoma
agus 1 a bharrachd

A’ fastadhÌre 1/2

Suas gu aois 22 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Seattle Children's Hospital, Seattle

A’ fastadhÌre 3

29 Days – 21 Years · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

University of Washington, Seattle

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT06001788

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadh

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT06710418

Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia

Fred Hutchinson Cancer Center/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Lùna 2026 · NCT03737955

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

Fred Hutchinson Cancer Center, Seattle

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT06529731

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 2

6 Months – 65 Years · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06013423

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT07046078

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Fred Hutchinson Cancer Research Center, Seattle

A’ fastadhSgrùdadh amharc

Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 1/2

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT03670966

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 1/2

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT03128034

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain

6 Months · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT04195633

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 1

Suas gu aois 80 · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT03326921

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Cèit 2026 · NCT06928662

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Seattle Cancer Care Alliance, Seattle

A’ fastadhÌre 2/3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Gibl 2026 · NCT04256317

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Gibl 2026 · NCT04797767

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Fred Hutchinson Cancer Center, Seattle

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT05732103

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Fred Hutchinson Cancer Center, Seattle

A’ fastadhÌre 2

Aoisean 18 gu 66 · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06859424

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Fred Hutch/University of Washington Cancer Consortium, Seattle

A’ fastadhÌre 2

Aoisean 1 gu 60 · Gach gnè · Air ùrachadh 12 Màrt 2026 · NCT03970096

PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML

Seattle Children's Hospital, Seattle

A’ fastadhÌre 1

Suas gu aois 30 · Gach gnè · Air ùrachadh 23 Dùbh 2025 · NCT05105152

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

Fred Hutchinson Cancer Research Center, Seattle

A’ fastadhÌre 2

3 Months · Gach gnè · Air ùrachadh 12 Samh 2025 · NCT02143830

Novel Digital Application for Patients With Acute Leukemia

Fred Hutchinson Cancer Research Center (FHCRC), Seattle

A’ fastadh

Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 10 Samh 2025 · NCT06472128

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Fred Hutchinson Cancer Center, Seattle

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2025 · NCT06501196

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.